NCT05945394View on ClinicalTrials.gov

The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human

UnknownOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

December 31, 2023

Conditions
Coronary Heart Disease, Susceptibility to, 1
Interventions
OTHER

No intervention

This is an obvertional study, and there is no intervention.

Trial Locations (1)

223300

RECRUITING

Huai'an First People's Hospital, Huai'an

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER

NCT05945394 - The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human | Biotech Hunter | Biotech Hunter